Director, Early-Phase Oncology Clinical Development

BioSpace; Radnor (Delaware County); Vor Ort; USD 250.000 - 360.000; Vollzeit

Zusammenfassung

Immunocore is seeking a Director of Oncology Clinical Development Physician (Early) to lead strategy and medical oversight for oncology programs. The role focuses on designing innovative early-phase trials, developing biomarker strategies, and providing expert guidance to cross-functional teams across global sites.

The candidate will interact with management, academic centers, regulatory authorities, and payors, driving strategic clinical leadership and integral trial design while ensuring

Qualifikationen

• MD or MD/PhD with research training and a clinical perspective.
• Strong understanding of pharmacokinetics, biomarkers, statistics, and regulatory requirements.
• Broad oncology knowledge; experience in immuno-oncology highly desirable.
• At least 3 years of relevant experience in clinical drug development across academia or pharma (including early-phase trials).
• 2+ years as a medical monitor in biotech/pharma or CRO.

Aufgaben

• Lead and shape future clinical development strategy and plans with cross-functional teams.
• Ensure development plans include key decision points, readouts, and risk mitigation.
• Design high-quality clinical trial protocols for lead oncology programs.
• Maintain relationships with key opinion leaders and partners for external collaborations.
• Provide medical oversight of studies, data review, interpretation, and reporting.

Kenntnisse

Leadership

Strategic thinking

Communication skills

Cross-functional collaboration

Mentorship

Ausbildung

MD or MD/PhD with research training

Clinical pharmacology knowledge

Jobbeschreibung

Immunocore is seeking a Director of Oncology Clinical Development Physician (Early) to lead strategy and medical oversight for oncology programs. The role focuses on designing innovative early-phase trials, developing biomarker strategies, and providing expert guidance to cross-functional teams across global sites.

The candidate will interact with management, academic centers, regulatory authorities, and payors, driving strategic clinical leadership and integral trial design while ensuring